Quick Takeaways
- RZLT - Rezolute, Inc. has 12 insiders with reported activity on this page.
- Net insider value flow over the last year: +$4,330,057.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 12 Insiders of Rezolute, Inc.
- Symbol
- RZLT on Nasdaq
- Location
- Redwood City, CA
What Changed
- Buy value: $4,330,057; sell value: $0.
- Net share flow: +1,384,644.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$4,330,057.
Buys
$4,330,057
Shares: 1,384,644
Insiders: 7
Sells
$0
Shares: 0
Insiders: 0
Net
+$4,330,057
Shares: +1,384,644
Insiders: 7
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 10,000 | 0 | $28,500 | $0 | +$28,500 |
| 3-6 | 133,299 | 0 | $260,372 | $0 | +$260,372 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 1,241,345 | 0 | $4,041,185 | $0 | +$4,041,185 |
Rezolute, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Genexine Inc. | 10%+ Owner | $173,462,643 | Mixed | 26 Apr 2019 | ||
| Young-Jin Kim | Director | $78,981,947 | +$3,999,999 | +5.3% | Mixed | 19 Nov 2025 |
| HANDOK, INC. | Director, 10%+ Owner | $10,051,937 | Mixed | 15 Oct 2021 | ||
| Nevan C. Elam | CEO, Director | $2,049,093 | +$50,880 | +2.5% | Mixed | 02 Mar 2026 |
| Daron Evans | Cfo | $1,410,136 | +$181,494 | +15% | Mixed | 30 Mar 2026 |
| Brian Kenneth Roberts | Chief Medical Officer | $1,043,459 | +$58,539 | +5.9% | Mixed | 02 Mar 2026 |
| Gil M. Labrucherie | Director | $1,002,371 | Mixed | 19 Nov 2025 | ||
| Nerissa Kreher | Director | $538,313 | +$9,997 | +1.9% | Mixed | 19 Nov 2025 |
| Philippe Fauchet | Director | $510,045 | Mixed | 19 Nov 2025 | ||
| Sunil Patilal Karnawat | Chief Commercial Officer | $209,091 | +$19,599 | +10% | Mixed | 15 Dec 2025 |
| Wladimir Hogenhuis | Director | $202,250 | +$9,549 | +5% | Filing P/S | 16 Dec 2025 |
| Erik Harris | Director | $192,990 | Mixed | 19 Nov 2025 |
Top shareholders of Rezolute, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Genexine Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
91,300,933
|
$173,462,643 | — | 26 Apr 2019 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
13F
|
RA Capital Healthcare Fund, L.P. · Company |
9.9%
|
15,302,186
|
$146,288,898 | $0 | 11 Dec 2025 | |
| Young-Jin Kim |
3/4/5
|
Director |
—
mixed-class rows
|
8,606,336
mixed-class rows
|
$78,981,947 | +$3,999,999 | 19 Nov 2025 | |
| Opaleye Management Inc. |
13D/G
13F
|
Company |
5.3%
|
4,912,900
|
$46,967,324 | $0 | 12 Dec 2025 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
5.4%
|
4,881,509
|
$45,886,185 | $0 | 30 Sep 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
18%
|
16,534,712
|
$39,021,920 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13D/G
13F
|
Company |
6.5%
|
6,064,486
|
$14,372,832 | $0 | 31 Dec 2025 | |
| Nantahala Capital Management, LLC |
13D/G
|
— |
4.9%
|
2,857,982
|
$11,317,609 | -$8,350,591 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.1%
|
4,788,511
|
$11,300,886 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
4.8%
|
4,506,861
|
$10,636,192 | — | 31 Dec 2025 | |
| HANDOK, INC. |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
5,942,617
|
$10,051,937 | — | 15 Oct 2021 | |
| STATE STREET CORP |
13F
|
Company |
4.3%
|
3,981,708
|
$9,396,831 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
3%
|
2,816,291
|
$6,646,447 | — | 31 Dec 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
2.5%
|
2,351,144
|
$5,548,700 | — | 31 Dec 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
2.5%
from 13D/G
|
2,305,568
|
$5,441,140 | — | 31 Dec 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
2.1%
|
2,000,000
|
$4,720,000 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
1,954,733
|
$4,614,157 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
2%
|
1,911,066
|
$4,510,115 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.8%
|
1,711,194
|
$4,038,418 | — | 31 Dec 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.8%
|
1,686,000
|
$3,978,960 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
1,516,435
|
$3,578,786 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
1.5%
|
1,407,699
|
$3,322,170 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
1,304,782
|
$3,079,286 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.2%
|
1,093,925
|
$2,581,663 | — | 31 Dec 2025 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1%
|
951,809
|
$2,246,269 | — | 31 Dec 2025 | |
| Nevan C. Elam |
3/4/5
|
CEO, Director |
—
mixed-class rows
|
799,501
mixed-class rows
|
$2,049,093 | +$50,880 | 02 Mar 2026 | |
| 22NW, LP |
13F
|
Company |
0.88%
|
820,653
|
$1,936,741 | — | 31 Dec 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.8%
|
750,000
|
$1,770,000 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.79%
|
737,315
|
$1,740,063 | — | 31 Dec 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.75%
|
697,855
|
$1,646,938 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.72%
|
671,692
|
$1,585,194 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.71%
|
665,158
|
$1,569,773 | — | 31 Dec 2025 | |
| Daron Evans |
3/4/5
|
CFO |
—
mixed-class rows
|
574,462
mixed-class rows
|
$1,410,136 | +$181,494 | 30 Mar 2026 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.55%
|
513,765
|
$1,212,485 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.52%
|
481,949
|
$1,137,400 | — | 31 Dec 2025 | |
| Brian Kenneth Roberts |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
384,413
mixed-class rows
|
$1,043,459 | +$58,539 | 02 Mar 2026 | |
| Gil M. Labrucherie |
3/4/5
|
Director |
—
mixed-class rows
|
121,072
mixed-class rows
|
$1,002,371 | — | 19 Nov 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.4%
|
374,068
|
$882,000 | — | 31 Dec 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.39%
|
368,166
|
$868,872 | — | 31 Dec 2025 | |
| David M. Knott Jr. |
13F
|
Individual |
0.36%
|
340,000
|
$802,400 | — | 31 Dec 2025 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.32%
|
296,843
|
$700,549 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.29%
|
271,073
|
$639,733 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.27%
|
249,390
|
$588,560 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.27%
|
248,679
|
$586,882 | — | 31 Dec 2025 | |
| Nerissa Kreher |
3/4/5
|
Director |
—
mixed-class rows
|
75,576
mixed-class rows
|
$538,313 | +$9,997 | 19 Nov 2025 | |
| Philippe Fauchet |
3/4/5
|
Director |
—
mixed-class rows
|
67,500
mixed-class rows
|
$510,045 | — | 19 Nov 2025 | |
| Caitong International Asset Management Co., Ltd |
13F
|
Company |
0.22%
|
209,179
|
$493,662 | — | 31 Dec 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.22%
|
206,265
|
$486,785 | — | 31 Dec 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.16%
|
150,586
|
$355,000 | — | 31 Dec 2025 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.16%
|
149,952
|
$353,887 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for Rezolute, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Daron Evans | RZLT | Common Shares | Purchase | 2.47% | $28,500 | $2.85 | 10,000 | 414,462 | 30 Mar 2026 | Direct |
| Brian Kenneth Roberts | RZLT | Common Shares | Tax liability | -3.71% | -11,439 | 296,913 | 02 Mar 2026 | Direct | ||
| Daron Evans | RZLT | Common Shares | Tax liability | -2.75% | -11,438 | 404,462 | 02 Mar 2026 | Direct | ||
| Nevan C. Elam | RZLT | Common Shares | Tax liability | -4.31% | -27,618 | 613,501 | 02 Mar 2026 | Direct | ||
| Wladimir Hogenhuis | RZLT | Common Shares | Purchase | 4.96% | $9,548 | $1.69 | 5,650 | 119,675 | 16 Dec 2025 | Direct |
| Brian Kenneth Roberts | RZLT | Common Shares | Purchase | 9.99% | $47,600 | $1.70 | 28,000 | 308,352 | 16 Dec 2025 | Direct |
| Daron Evans | RZLT | Common Shares | Purchase | 55.6% | $4,475 | $1.79 | 2,500 | 7,000 | 15 Dec 2025 | Held by minor child #3 |
| Daron Evans | RZLT | Common Shares | Purchase | 55.6% | $4,462 | $1.78 | 2,500 | 7,000 | 15 Dec 2025 | Held by minor child #2 |
| Daron Evans | RZLT | Common Shares | Purchase | 10.6% | $70,640 | $1.77 | 40,000 | 415,900 | 15 Dec 2025 | Direct |
| Nevan C. Elam | RZLT | Common Shares | Purchase | 5.25% | $50,880 | $1.59 | 32,000 | 641,119 | 15 Dec 2025 | Direct |
| Sunil Patilal Karnawat | RZLT | Common Shares | Purchase | 20.4% | $19,599 | $1.62 | 12,100 | 71,542 | 15 Dec 2025 | Direct |
| Daron Evans | RZLT | Common Shares | Purchase | 8.69% | $53,167 | $5.04 | 10,549 | 131,900 | 09 Dec 2025 | Direct |
| Brian Kenneth Roberts | RZLT | Common Shares | Award | 78.2% | 123,000 | 280,352 | 19 Nov 2025 | Direct | ||
| Brian Kenneth Roberts | RZLT | Employee Stock Option (Right to Buy) | 72,000 | 72,000 | 19 Nov 2025 | Direct | ||||
| Sunil Patilal Karnawat | RZLT | Common Shares | Award | 116.6% | 32,000 | 59,442 | 19 Nov 2025 | Direct | ||
| Sunil Patilal Karnawat | RZLT | Employee Stock Option (Right to Buy) | Award | 19,000 | 19,000 | 19 Nov 2025 | Direct | |||
| Nevan C. Elam | RZLT | Common Shares | Award | 108.5% | 317,000 | 609,119 | 19 Nov 2025 | Direct | ||
| Nevan C. Elam | RZLT | Employee Stock Option (Right to Buy) | Award | 186,000 | 186,000 | 19 Nov 2025 | Direct | |||
| Daron Evans | RZLT | Common Shares | Award | 39.8% | 107,000 | 375,900 | 19 Nov 2025 | Direct | ||
| Daron Evans | RZLT | Employee Stock Option (Right to Buy) | Award | 63,000 | 63,000 | 19 Nov 2025 | Direct | |||
| Nerissa Kreher | RZLT | Common Shares | Award | 55.9% | 21,000 | 58,576 | 19 Nov 2025 | Direct | ||
| Nerissa Kreher | RZLT | Director Stock Option (Right to Buy) | Award | 12,000 | 12,000 | 19 Nov 2025 | Direct | |||
| Wladimir Hogenhuis | RZLT | Common Shares | Award | 22.6% | 21,000 | 114,025 | 19 Nov 2025 | Direct | ||
| Wladimir Hogenhuis | RZLT | Director Stock Option (Right to Buy) | Award | 12,000 | 12,000 | 19 Nov 2025 | Direct | |||
| Erik Harris | RZLT | Common Shares | Award | 21,000 | 21,000 | 19 Nov 2025 | Direct | |||
| Erik Harris | RZLT | Director Stock Option (Right to Buy) | Award | 12,000 | 12,000 | 19 Nov 2025 | Direct | |||
| Young-Jin Kim | RZLT | Common Shares | Award | 14% | 21,000 | 170,950 | 19 Nov 2025 | Direct | ||
| Young-Jin Kim | RZLT | Director Stock Option (Right to Buy) | Award | 12,000 | 12,000 | 19 Nov 2025 | Direct | |||
| Philippe Fauchet | RZLT | Common Shares | Award | 60.9% | 21,000 | 55,500 | 19 Nov 2025 | Direct | ||
| Philippe Fauchet | RZLT | Director Stock Option (Right to Buy) | Award | 12,000 | 12,000 | 19 Nov 2025 | Direct | |||
| Gil M. Labrucherie | RZLT | Common Shares | Award | 60.9% | 21,000 | 55,500 | 19 Nov 2025 | Direct | ||
| Gil M. Labrucherie | RZLT | Director Stock Option (Right to Buy) | Award | 12,000 | 12,000 | 19 Nov 2025 | Direct | |||
| Sunil Patilal Karnawat | RZLT | Common Shares | Award | 1023.8% | 25,000 | 27,442 | 18 Aug 2025 | Direct | ||
| Sunil Patilal Karnawat | RZLT | Employee Stock Option (Right to Buy) | Award | 275,000 | 275,000 | 18 Aug 2025 | Direct | |||
| Brian Kenneth Roberts | RZLT | Common Shares | Purchase | 19.2% | $10,939 | $4.38 | 2,500 | 15,500 | 25 Jun 2025 | Direct |
| Daron Evans | RZLT | Common Shares | Purchase | 1.89% | $20,250 | $4.05 | 5,000 | 268,900 | 24 Jun 2025 | Direct |
| Young-Jin Kim | RZLT | Common Shares | Purchase | 17.1% | $3,999,999 | $3.25 | 1,230,769 | 8,423,386 | 13 Jun 2025 | Held by Handok, Inc. |
| Nerissa Kreher | RZLT | Common Shares | Purchase | 8.92% | $9,997 | $3.25 | 3,076 | 37,576 | 13 Jun 2025 | Direct |
| Nerissa Kreher | RZLT | Common Shares | Award | 35.3% | 9,000 | 34,500 | 10 Jun 2025 | Direct | ||
| Nerissa Kreher | RZLT | Director Stock Options (Right to Buy) | Award | 5,000 | 5,000 | 10 Jun 2025 | Direct | |||
| Gil M. Labrucherie | RZLT | Common Shares | Award | 35.3% | 9,000 | 34,500 | 10 Jun 2025 | Direct | ||
| Gil M. Labrucherie | RZLT | Director Stock Option (Right to Buy) | Award | 5,000 | 5,000 | 10 Jun 2025 | Direct | |||
| Wladimir Hogenhuis | RZLT | Common Shares | Award | 10.7% | 9,000 | 93,025 | 10 Jun 2025 | Direct | ||
| Wladimir Hogenhuis | RZLT | Director Stock Option (Right to Buy) | Award | 5,000 | 5,000 | 10 Jun 2025 | Direct | |||
| Young-Jin Kim | RZLT | Common Shares | Award | 6.39% | 9,000 | 149,950 | 10 Jun 2025 | Direct | ||
| Young-Jin Kim | RZLT | Director Stock Option (Right to Buy) | Award | 5,000 | 5,000 | 10 Jun 2025 | Direct | |||
| Daron Evans | RZLT | Common Shares | Award | 10.9% | 26,000 | 263,900 | 10 Jun 2025 | Direct | ||
| Daron Evans | RZLT | Employee Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 10 Jun 2025 | Direct | |||
| Philippe Fauchet | RZLT | Common Shares | Award | 35.3% | 9,000 | 34,500 | 10 Jun 2025 | Direct | ||
| Philippe Fauchet | RZLT | Director Stock Option (Right to Buy) | Award | 5,000 | 5,000 | 10 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.